EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Danaher Corp. (0R2B) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Danaher Corp. $77.47, price $215, upside -64.0%, quality 71 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? Yes
  3. Add to watchlist

Industrials · GB · Home US

DC Some data Sep 24, 2026

Danaher Corp.

0R2B · LSE

Stretched ValuationStrong overvaluation with only moderate quality.

!Fair value $77.47 · Strongly overvalued (−64.0%)
✓Quality 71/100
!Weak Growth (revenue 5y +2.0 %/yr)
✓Solidly profitable · 16.0% net margin (TTM)
✓Low debt · generates free cash flow
✓0.7% dividend yield · Well covered
✓Ranks above peers (6/10)
!Moderate moat 59/100
!Evidence only medium, so the estimate is less certain
!Weak on future: 28 out of 100
!Weak on dividend: 13 out of 100
Watch Danaher Corp. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$288.78 $161.84 Fair Value $77.47 Jun 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range $161.84 – $288.78 · fair‑value band $52.98 – $109.24 · the $214.93 price screens above the $77.47 fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow Danaher in your weekly email

Every Wednesday you see whether Danaher is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments.

Show more

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Stock analysis

Danaher Corp. (0R2B) currently trades at $214.93, while our model-based Fair Value estimate is $77.47, 64.0% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of $87.66 per share, and 0 of the 12 models we run sit above the $214.93 price.

Bear case: the Dividend Discount group reads lowest at $15.77, and 12 of the 12 models stay below the price. Evidence for this calculation is medium.

Scenario range: $52.98 (bear) to $109.24 (bull), the price of $214.93 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 71/100 (solid quality), in the Industrials sector.

Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.

Danaher Corp. reported revenue of $24.6B in FY2025 versus $29.5B in FY2021, a compound −4.4%/yr. Reported net income was $3.6B in FY2025, compounding −13.4%/yr from FY2021.

Key figures

Market cap $154B · P/E ratio 0.2 · P/S ratio 0.03 · EPS (TTM) $8.64 · Dividend yield 0.7% · Net margin 14.7% · Return on equity 7.6% · Return on assets (EBIT) 7.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (medium confidence).

What moves the price

The share trades about 11% below its 52-week high and 33% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −34% fair-value upside, at −64%, 0R2B screens richer than that median.

Fair Value models

Bear $52.98 Fair Value $77.47 Bull $109.24
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($5.44 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Growth DCF $55.61 $84.84 $122.77 78
Owner Earnings $48.58 $78.05 $117.91 76
Residual Income $60.20 $62.84 $68.45 76
All 12 models by family
DCF Models
Owner Earnings $48.58 $78.05 $117.91 76
5Y P/E Exit $48.72 $84.82 $120.31 70
10Y P/E Exit $49.85 $79.73 $112.43 63
Earnings-Based
Graham-Dodd $35.06 $78.45 $100.27 65
Dividend Discount
Gordon GGM $11.00 $17.36 $24.21 68
DDM Multi-Stage $11.00 $15.77 $20.90 67
Multiples
P/E Multiple $81.21 $108.28 $135.35 63
P/B Multiple $65.74 $87.66 $109.57 55
Asset-Based
NCAV (Graham) $37.48 $50.22 $74.95 54
Growth DCF
Growth DCF $55.61 $84.84 $122.77 78
Rev-Margin DCF $30.35 $53.67 $78.79 72
Economic Profit
Residual Income $60.20 $62.84 $68.45 76

Open the full fair value analysis →

Notify me when 0R2B reaches fair value

Put 0R2B on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 71/100

Of which business quality 68 · Market factors (momentum, volatility) 56

Profitability 36
Margins and returns on capital today
Quality Growth 37
Are margins and returns improving?
Cashflow 85
Earnings quality: real cash, not paper profit
Fin. Strength 73
Balance sheet, leverage, solvency risk
Investment 92
Disciplined investing over empire-building
Low Volatility 71
Calm price path (market factor)
Momentum 48
Price trend over the last 3–12 months (market factor)
52W Momentum 51
Distance to the 52-week high (market factor)
Net Issuance 96
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+2.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.0%
Start year 2020 (pandemic). Over 10 years: +5.5% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.3%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+0.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year−0.1%
Dividend (yield on the price)0.7%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−0.1% vs 7.4%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.19% → 19%
Start year 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+24.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+7.0%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +21.1% a year for the price and +4.5% for the forecasts.
Forecast 2026 (sales)+7.2%
Forecast 2027 (sales)+8.0%
Projected 2028 (sales)+7.3%
Projected 2029 (sales)+6.5%
Projected 2030 (sales)+5.8%

0R2B screens overvalued: fair value 64% below the price. Compare with Princess Private Equity Holding →

Compare Danaher Corp. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Industrial Conglomerates” was too small, so the broader sector is used.)Industrials · 5266 stocks

Beats the sector median on 6/10 measures
Overall it ranks above its sector peers.
Valuation
Quality Score 71 · Top 25%
Fair Value upside −64.0% · Bottom 25%
Profitability
Return on equity (TTM) 7.6% · Above median
Return on assets 4.0% · Above median
Net margin (TTM) 16.0% · Top 25%
Operating margin (TTM) 19.8% · Top 25%
Growth and dividend
Revenue growth 5.5% · Below median
Dividend yield (TTM) 0.7% · Bottom 25%
Balance sheet
Debt / equity 0.42× · Above median

Valuation Multiplesvs Industrials median · lower = cheaper

P/E (TTM) 0.2× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 17
FUTURE (revenue growth)28 · sector 35
PAST (return on equity)30 · sector 29
HEALTH (low debt)79 · sector 94
DIVIDEND (yield)13 · sector 37

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Industrial Conglomerates stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Princess Private Equity Holding PEYS £5.83 £9.55 +64%
Contemporary Amperex Technology Co 300750 ¥291.11 ¥695.24 +139%
Delta Electronics (Thailand) Public Company DELTA 263.00 THB 38.64 THB −85%
Larsen & Toubro Limited LT ₹3,876 ₹1,994 −49%
Samsung C&T Corporation 028260 367,000 KRW 159,718 KRW −56%
Adani Ports and Special Economic Zone Limited ADANIPORTS ₹1,738 ₹1,041 −40%
Hanwha Aerospace Co 012450 1,021,000 KRW 678,284 KRW −34%
ASELSAN Elektronik Sanayi ve Ticaret Anonim Sirketi ASELS 372.25 TRY 63.11 TRY −83%
HD Hyundai Heavy Industries Co 329180 441,000 KRW 485,100 KRW +10%
Airports of Thailand Public Company AOT 62.25 THB 54.20 THB −13%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Danaher Corp. · Fair Value
$77.47 −64%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Danaher Corp. Fair Value". https://www.fairvalue-calculator.com/stock/0R2B

Frequently asked questions

Is Danaher Corp. (0R2B) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $77.47 versus a price of $214.93, about −64% upside (overvalued).
What is the fair value of 0R2B?
Our model-based fair value for Danaher Corp. is $77.47 (as of Sep 24, 2026), built from audited fundamentals. The current price: $214.93.
What is the quality score of 0R2B?
Danaher Corp. has a Quality Score of 71/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Danaher Corp. (0R2B)?
Our model-based price target is the fair value of $77.47 (as of Sep 24, 2026) from 12 valuation models. Cautious scenario $52.98, optimistic scenario $109.24. It is a calculation from audited fundamentals, not an analyst target.
What is the Danaher Corp. stock forecast for 2026?
Our models put fair value at $77.47, about −64% upside versus a price of $214.93 (overvalued). Cautious scenario $52.98, optimistic scenario $109.24. The calculation is refreshed regularly with new filings.
What is the revenue of Danaher Corp. (0R2B)?
Danaher Corp. reported trailing-twelve-month revenue of about $25.1B (latest available figure, as of Sep 24, 2026).
Does Danaher Corp. pay a dividend?
Danaher Corp. currently shows a dividend yield of about 0.67% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Danaher Corp. (0R2B)?
For today's price to be fair in a discounted-cash-flow model, Danaher Corp. would have to grow free cash flow by +24.0 % per year for five years (discount rate 9.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +2.0 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 0R2B use?
Our models discount Danaher Corp. at 9.8 %: a base by market capitalisation (unknown), damped by beta 0.82, country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Danaher Corp. that is +24.0 % per year a year over ten years, using the same discount rate (9.8 %) and the same formula as our fair value.
How much growth has Danaher Corp. (0R2B) delivered so far?
Over the past 5 years revenue at Danaher Corp. grew +2.0 % a year. The price currently implies +24.0 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Danaher Corp. (0R2B) growing?
The median revenue growth in the sector is +7.0 % a year. That is the yardstick for the growth priced into Danaher Corp. (+24.0 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Danaher Corp. (0R2B)?
The free-cash-flow yield on the price is 2.57 %: that much free cash flow Danaher Corp. produces per unit of market value. When it exceeds the discount rate of our models (9.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Danaher Corp. (0R2B)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Danaher Corp. it is $77.47 per share (as of Sep 24, 2026), against a price of $214.93. It is the blended result of 12 valuation models (cash flow, earnings, asset, dividend).
Is Danaher Corp. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 0R2B trades above its calculated fair value: price $214.93, fair value $77.47, a gap of about −64% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0R2B?
No. The price is what the market pays today ($214.93); the fair value is what the company's own numbers justify ($77.47). For Danaher Corp. the two are $137.46 per share apart. That gap is exactly why we show both numbers side by side.
How much is Danaher Corp. worth?
The market values Danaher Corp. at about $154B (market capitalisation, as of Sep 24, 2026). Per share that is $214.93; our models calculate a fair value of $77.47 per share.
What do the bullish and bearish scenarios say about 0R2B?
Our models span a range for Danaher Corp.: cautious scenario $52.98, base $77.47, optimistic $109.24 per share (as of Sep 24, 2026, price $214.93). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 0R2B?
Danaher Corp. trades at a price-to-earnings ratio of 0.2 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $77.47 is built from several models across several years.
How solid is the balance sheet of Danaher Corp. (0R2B)?
Balance-sheet figures for Danaher Corp. (as of Sep 24, 2026): return on equity 7.6%, debt of 0.42 per unit of equity. They feed the Quality Score of 71/100, which measures business quality independently of the share price.
How far is 0R2B from its 52-week high?
Danaher Corp. trades at $214.93, about 11% below its 52-week high of $241.48 and 33% above the low of $161.84 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $77.47 is for.
Which stocks are comparable to Danaher Corp.?
From the same area (Industrials) we also value Princess Private Equity Holding, Contemporary Amperex Technology Co, Delta Electronics (Thailand) Public Company, Larsen & Toubro Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Danaher Corp. stock attractive at the current price?
The data as of Sep 24, 2026: price $214.93, calculated fair value $77.47 (−64%), Quality Score 71/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0R2B calculated?
We run Danaher Corp. through 12 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $77.47, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Danaher Corp. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Danaher Corp. (0R2B)?
The closing price on Oct 2, 2026 was $214.93. Our model-based fair value is $77.47, about −64% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Danaher Corp. right now?
A high-quality business (quality 71/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case ($109.24). The favourable scenario is already priced in. A fairly wide model range ($52.98 to $109.24) leaves room in how you read the outcome.
Where does the earnings growth of Danaher Corp. (0R2B) come from?
Earnings per share at Danaher Corp. grew +8.0 % a year from 2014 to 2025. Broken into its drivers: revenue per share +5.2 %, EBIT margin +2.5 %, tax rate +0.2 %, residual (interest, one-offs) −0.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Danaher Corp.

How large is the market capitalisation of Danaher Corp. (0R2B)?
The market capitalisation of Danaher Corp. is $154B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Danaher Corp. (0R2B)?
The price-to-sales ratio of Danaher Corp. is 0.03 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Danaher Corp. (0R2B)?
Earnings per share at Danaher Corp. are $8.64 (price ÷ EPS = P/E 0.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Danaher Corp. (0R2B)?
The dividend yield of Danaher Corp. is 0.7% (payout 16.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Danaher Corp. (0R2B)?
The net margin of Danaher Corp. is 14.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Danaher Corp. (0R2B)?
The return on equity (ROE) of Danaher Corp. is 7.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Danaher Corp. (0R2B)?
On an EBIT basis the return on assets of Danaher Corp. is 7.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Danaher Corp. (0R2B)?
The operating margin of Danaher Corp. is 19.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Danaher Corp. (0R2B)?
Revenue at Danaher Corp. is growing +5.5% versus a year earlier (3y avg −2.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Danaher Corp. (0R2B)?
Earnings per share at Danaher Corp. are growing +59.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Danaher Corp. (0R2B) carry?
The net debt of Danaher Corp. is $13.8B (fiscal year 2025, ≈ 2.6 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Danaher Corp. in the live analysis

One click puts Danaher Corp. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.